On the 10th of June, Altor Fund III (Altor) signed an agreement to divest Curato Røntgen AS (Curato) - the number one private provider of radiology in Norway to Aleris, a leading private health-care company in Scandinavia.
Curato is the largest private radiology (medical diagnostic imaging) supplier in Norway with 13 clinics across the country. In total, the company greets about 360,000 patients and performs more than 600,000 examinations every year. Since 2015 Curato also has one clinic in Uppsala, Sweden, specialized in mammography and in 2016 won procurements for two additional clinics in Blekinge. During Altor’s ownership Curato has continued to improve the service and quality of its offering, and both revenues and EBITDA have grown significantly between 2013 and 2015 (26% and 45% respectively).
“It has been a pleasure working together with Curato”, says Maria Tallaksen, Director at Altor Equity Partners and Board member of Curato. “The Curato team is truly passionate about delivering high-quality services to all customers and has reinforced its position throughout Norway and Sweden during this period. I believe Aleris will be a great new partner to Curato on their future journey. The combined group will deliver an improved service to patients and society”.
“Becoming a part of Aleris will result in us becoming an integrated part in a bigger, Scandinavian group with a wider range of specialized medical services”, says Erik Kreyberg Normann, CEO of Curato. “The partnership with Altor has been fruitful and I believe our new owner will enable a further growth and increased knowledge-sharing between clinics and specialities”.
The transaction is subject to customary regulatory requirements and approvals.